1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of Continuous Renal Replacement Therapy Market By Type (Dialysates And Replacement Fluid, Bloodline Sets, Disposables Hemofilters, Other Disposables And Systems), By Modality (Slow Continuous Filtration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration), By End User (Hospitals, Clinics And Others) And By Region (Global Market Forecast To 2025)

Global Market Analysis Of Continuous Renal Replacement Therapy Market By Type (Dialysates And Replacement Fluid, Bloodline Sets, Disposables Hemofilters, Other Disposables And Systems), By Modality (Slow Continuous Filtration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration), By End User (Hospitals, Clinics And Others) And By Region (Global Market Forecast To 2025)

Publication Month: Feb 2020 | No. of Pages: 122 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

The Global Continuous Renal Replacement Therapy market is estimated to reach $ 1.62 billion by 2025 from $ 868 million in 2018; growing at a CAGR of 7.6% from 2019 to 2025.

Continuous Renal Replacement Therapy is an extracorporeal blood purification therapy. CRRT’s function is the same as that of the kidney’s function, which regulates the water, electrolytes, and toxic products by a continuous slow removal of solutes and fluid. Continuous renal replacement therapy is indicated in patients who are not able to tolerate the conventional intermittent hemodialysis and this is due to hemodynamic instability.

Market Dynamics

The Global Continuous Renal Replacement market is primarily driven by factors such as increasing population with end-stage renal diseases, increasing acute kidney injury among the ICU patients, rising focus on research and development, technological advancement, and growing awareness are some of the major forces that drive the market.

Market Segmentation

The Global Continuous Renal Replacement Therapy market is mainly classified based on type, modality and region.

Based on Type, the market is further segmented into Dialysates and Replacement Fluid, Bloodline Sets, Disposables, Hemofilters, Other Disposables, and Systems.

Based on Modality, the market is further segmented into Slow Continuous Filtration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, and Continuous Venovenous Hemodiafiltration.

Based on End User, the market is further segmented into Hospitals, Clinics and Other.

Regional Analysis

Based on geography, the Global Continuous Renal Replacement Therapy market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Global Continuous Renal Replacement Therapy Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Continuous Renal Replacement Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2018-2025, this study provides the Global Continuous Renal Replacement Therapy sales, revenue, and market share for each player covered in this report.

The major players covered in Global Continuous Renal Replacement Therapy are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., NxStage Medical Inc., Nikkiso Co. Ltd., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Bellco S.R.L., Toray Medical Co. Ltd., Informed SA, Medica SpA, Medical Components Inc., Medites Pharma Spol. S.R.O., Medtronic plc, SWS Hemodialysis Care Co. Ltd., Ningbo Tianyi Medical Appliance Co. Ltd., and Others.

Continuous Renal Replacement Therapy Market Key Segments:

By Type

  • Dialysates and Replacement Fluid
  • Bloodline Sets
  • Disposables
  • Hemofilters
  • Other Disposables
  • Systems

By Modality

  • Slow Continuous Filtration
  • Continuous Venovenous Hemofiltration
  • Continuous Venovenous Hemodialysis
  • Continuous Venovenous Hemodiafiltration

By End-User

  • Hospitals
  • Clinics
  • Other

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1 Market Overview

1.1 Continuous Renal Replacement Therapy Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Continuous Renal Replacement Therapy Revenue by Type: 2019 VS 2021 VS 2025

1.2.2 Dialysates and Replacement Fluid

1.2.3 Bloodline Sets

1.2.4 Disposables

1.2.5 Hemofilters

1.2.6 Other Disposables

1.2.7 Systems

1.3 Market Analysis by Modality

1.3.1 Overview: Global Continuous Renal Replacement Therapy Revenue by Modality: 2019 VS 2021 VS 2025

1.3.2 Slow Continuous Filtration

1.3.3 Continuous Venovenous Hemofiltration

1.3.4 Continuous Venovenous Hemodialysis 1.3.5 Continuous Venovenous Hemodiafiltration

1.4 Market Analysis by End User

1.4.1 Overview: Global Continuous Renal Replacement Therapy Revenue by End User: 2019 VS 2021 VS 2025

1.4.2 Hospitals

1.4.3 Clinics

1.4.4 Other

1.5 Overview of Global Continuous Renal Replacement Therapy Market

1.5.1 Global Continuous Renal Replacement Therapy Market Status and Outlook (2019-2025)

1.5.2 North America (United States, Canada and Mexico)

1.5.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.5.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.5.5 South America, Middle East & Africa

1.6 Market Dynamics

1.6.1 Market Opportunities

1.6.2 Market Risk

1.6.3 Market Driving Force

2 Manufacturers Profiles

2.1 Fresenius Medical care AG & Co. KGaA

2.1.1 Fresenius Medical care AG & Co. KGaA Details

2.1.2 Fresenius Medical care AG & Co. KGaA Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Fresenius Medical care AG & Co. KGaA SWOT Analysis

2.1.4 Fresenius Medical care AG & Co. KGaA Product and Services

2.1.5 Fresenius Medical care AG & Co. KGaA Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 Baxter International Inc.

2.2.1 Baxter International Inc. Details

2.2.2 Baxter International Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Baxter International Inc. SWOT Analysis

2.2.4 Baxter International Inc. Product and Services

2.2.5 Baxter International Inc. Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 NxStage Medical Inc.

2.3.1 NxStage Medical Inc. Details

2.3.2 NxStage Medical Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 NxStage Medical Inc. SWOT Analysis

2.3.4 NxStage Medical Inc. Product and Services

2.3.5 NxStage Medical Inc. Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 Nikkiso Co. Ltd.

2.4.1 Nikkiso Co. Ltd. Details

2.4.2 Nikkiso Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Nikkiso Co. Ltd. SWOT Analysis

2.4.4 Nikkiso Co. Ltd. Product and Services

2.4.5 Nikkiso Co. Ltd. Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 B. Braun Melsungen AG

2.5.1 B. Braun Melsungen AG Details

2.5.2 B. Braun Melsungen AG Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 B. Braun Melsungen AG SWOT Analysis

2.5.4 B. Braun Melsungen AG Product and Services

2.5.5 B. Braun Melsungen AG Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 Asahi Kasei Medical Co. Ltd.

2.6.1 Asahi Kasei Medical Co. Ltd. Details

2.6.2 Asahi Kasei Medical Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Asahi Kasei Medical Co. Ltd. SWOT Analysis

2.6.4 Asahi Kasei Medical Co. Ltd. Product and Services

2.6.5 Asahi Kasei Medical Co. Ltd. Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Bellco S.R.L

2.7.1 Bellco S.R.L Details

2.7.2 Bellco S.R.L Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Bellco S.R.L SWOT Analysis

2.7.4 Bellco S.R.L Product and Services

2.7.5 Bellco S.R.L Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Toray Medical Co. Ltd.

2.8.1 Toray Medical Co. Ltd. Details

2.8.2 Toray Medical Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Toray Medical Co. Ltd. SWOT Analysis

2.8.4 Toray Medical Co. Ltd. Product and Services

2.8.5 Toray Medical Co. Ltd. Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 Informed SA

2.9.1 Informed SA Details

2.9.2 Informed SA Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Informed SA SWOT Analysis

2.9.4 Informed SA Product & Services

2.9.5 Informed SA Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.10 Medica SpA

2.10.1 Medica SpA Details

2.10.2 Medica SpA Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Medica SpA SWOT Analysis

2.10.4 Medica SpA Product and Services

2.10.5 Medica SpA Continuous Renal Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Continuous Renal Replacement Therapy Sales and Market Share by Manufacturer (2019-2020)

3.2 Global Continuous Renal Replacement Therapy Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Continuous Renal Replacement Therapy Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Continuous Renal Replacement Therapy Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Continuous Renal Replacement Therapy Sales, Revenue and Market Share by Regions

4.1.1 Global Continuous Renal Replacement Therapy Sales and Market Share by Regions (2019-2020)

4.1.2 Global Continuous Renal Replacement Therapy Revenue and Market Share by Regions (2019-2020)

4.2 North America Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

4.3 Europe Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

4.4 Asia-Pacific Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

4.5 South America Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

4.6 Middle East and Africa Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

5 North America by Country

5.1 North America Continuous Renal Replacement Therapy Sales, Revenue and Market Share by Country

5.1.1 North America Continuous Renal Replacement Therapy Sales and Market Share by Country (2019-2020)

5.1.2 North America Continuous Renal Replacement Therapy Revenue and Market Share by Country (2019-2020)

5.2 United States Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

5.3 Canada Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

5.4 Mexico Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

6 Europe by Country

6.1 Europe Continuous Renal Replacement Therapy Sales, Revenue and Market Share by Country

6.1.1 Europe Continuous Renal Replacement Therapy Sales and Market Share by Country (2019-2020)

6.1.2 Europe Continuous Renal Replacement Therapy Revenue and Market Share by Country (2019-2020)

6.2 Germany Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

6.3 UK Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

6.4 France Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

6.5 Russia Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

6.6 Italy Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Continuous Renal Replacement Therapy Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Continuous Renal Replacement Therapy Sales and Market Share by Regions (2019-2020)

7.1.2 Asia-Pacific Continuous Renal Replacement Therapy Revenue and Market Share by Regions (2019-2020)

7.2 China Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

7.3 Japan Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

7.4 Korea Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

7.5 India Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

7.6 Southeast Asia Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

7.7 Australia Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

8 South America by Country

8.1 South America Continuous Renal Replacement Therapy Sales, Revenue and Market Share by Country

8.1.1 South America Continuous Renal Replacement Therapy Sales and Market Share by Country (2019-2020)

8.1.2 South America Continuous Renal Replacement Therapy Revenue and Market Share by Country (2019-2020)

8.2 Brazil Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

8.3 Argentina Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Continuous Renal Replacement Therapy Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Continuous Renal Replacement Therapy Sales and Market Share by Country (2019-2020)

9.1.2 Middle East & Africa Continuous Renal Replacement Therapy Revenue and Market Share by Country (2019-2020)

9.2 Saudi Arabia Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

9.3 Turkey Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

9.4 Egypt Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

9.5 South Africa Continuous Renal Replacement Therapy Sales and Growth Rate (2019-2020)

10 Global Continuous Renal Replacement Therapy Market Segment by Type

10.1 Global Continuous Renal Replacement Therapy Sales Market Share by Type (2019-2020)

10.2 Global Continuous Renal Replacement Therapy Revenue Market Share by Type (2019-2020)

10.3 Global Continuous Renal Replacement Therapy Price by Type (2019-2020)

11 Global Continuous Renal Replacement Therapy Market Segment by Modality

11.1 Global Continuous Renal Replacement Therapy Sales Market Share by Modality (2019-2020)

11.2 Global Continuous Renal Replacement Therapy Revenue Market Share by Modality (2019-2020)

11.3 Global Continuous Renal Replacement Therapy Price by Modality (2019-2020)

12 Global Continuous Renal Replacement Therapy Market Segment by End User

12.1 Global Continuous Renal Replacement Therapy Sales Market Share by End User (2019-2020)

12.2 Global Continuous Renal Replacement Therapy Revenue Market Share by End User (2019-2020)

12.3 Global Continuous Renal Replacement Therapy Price by End User (2019-2020)

13 Market Forecast

13.1 Global Continuous Renal Replacement Therapy Sales, Revenue and Growth Rate (2021-2025)

13.2 Continuous Renal Replacement Therapy Market Forecast by Regions (2021-2025)

13.2.1 North America Continuous Renal Replacement Therapy Market Forecast (2021-2025)

13.2.2 Europe Continuous Renal Replacement Therapy Market Forecast (2021-2025)

13.2.3 Asia-Pacific Continuous Renal Replacement Therapy Market Forecast (2021-2025)

13.2.4 South America Continuous Renal Replacement Therapy Market Forecast (2021-2025)

13.2.5 Middle East & Africa Continuous Renal Replacement Therapy Market Forecast (2021-2025)

13.3 Continuous Renal Replacement Therapy Market Forecast by Type (2021-2025)

13.3.1 Global Continuous Renal Replacement Therapy Sales Forecast by Type (2021-2025)

13.3.2 Global Continuous Renal Replacement Therapy Market Share Forecast by Type (2021-2025)

13.4 Continuous Renal Replacement Therapy Market Forecast by Modality (2021-2025)

13.4.1 Global Continuous Renal Replacement Therapy Sales Forecast by Modality (2021-2025)

13.4.2 Global Continuous Renal Replacement Therapy Market Share Forecast by Modality (2021-2025) 13.3 Continuous Renal Replacement Therapy Market Forecast by End User (2021-2025)

13.3.1 Global Continuous Renal Replacement Therapy Sales Forecast by End User (2021-2025)

13.3.2 Global Continuous Renal Replacement Therapy Market Share Forecast by End User (2021-2025)

14 Sales Channel, Distributors, Traders and Dealers

14.1 Sales Channel

14.1.1 Direct Marketing

14.1.2 Indirect Marketing

14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Data Source

16.3 Disclaimer

16.4 About US

 

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets